These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


162 related items for PubMed ID: 12480590

  • 1. [Clinical value of carbohydrate antigen 50 and carbohydrate antigen 242 in the diagnosis of colorectal carcinoma].
    Huang CW, Bai L.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1116-8. PubMed ID: 12480590
    [Abstract] [Full Text] [Related]

  • 2. [The clinical value of tumor marker CA50 and CA242 in digestive tract cancer].
    Huang C, Bei L, Liu T.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Aug; 20(4):285-8. PubMed ID: 11367693
    [Abstract] [Full Text] [Related]

  • 3. [Detection and clinical study of serum tumor markers in patients with colorectal cancer].
    Zhao XW, Jiang B, Han CZ, Jing JX.
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):286-8. PubMed ID: 15996321
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
    Wu X, Lu XH, Xu T, Qian JM, Zhao P, Guo XZ, Yang XO, Jiang WJ.
    Chin J Dig Dis; 2006 May; 7(3):170-4. PubMed ID: 16808798
    [Abstract] [Full Text] [Related]

  • 5. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG, Bai XF, Mao YL, Shao YF, Wu JX, Shan Y, Wang CF, Wang J, Tian YT, Liu Q, Xu DK, Zhao P.
    Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
    [Abstract] [Full Text] [Related]

  • 6. Tumor markers in staging and prognosis of colorectal carcinoma.
    Levy M, Visokai V, Lipska L, Topolcan O.
    Neoplasma; 2008 Mar; 55(2):138-42. PubMed ID: 18237252
    [Abstract] [Full Text] [Related]

  • 7. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
    Chen C, Chen LQ, Yang GL, Li Y.
    Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical evaluation of four tumor markers (CEA, TPA, CA50 and CA72-4) in colorectal cancer].
    Koizumi F, Odagiri H, Fujimoto H, Kawamura T, Ishimori A.
    Rinsho Byori; 1992 May; 40(5):523-8. PubMed ID: 1507478
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The diagnostic values of CA242 combining other tumor markers for lung cancer].
    Zhang S, Ma Y, Yang X.
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 May; 22(5):271-3. PubMed ID: 11775851
    [Abstract] [Full Text] [Related]

  • 14. [Clinical significance of plasma fibrinogen level in patients with colorectal cancer].
    Wang Q, Xie R, Zhang QY.
    Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):544-6. PubMed ID: 16438853
    [Abstract] [Full Text] [Related]

  • 15. [Clinical value of tumor-associated growth factor detection in the diagnosis of colorectal carcinoma].
    Yang J, Wang D.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Oct; 27(10):1577-9. PubMed ID: 17959542
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical value of determination of urokinase-type plasminogen activator antigen in plasma for detection of colorectal cancer: comparison with circulating tumor-associated antigens CA 19-9 and carcinoembryonic antigen.
    Huber K, Kirchheimer JC, Sedlmayer A, Bell C, Ermler D, Binder BR.
    Cancer Res; 1993 Apr 15; 53(8):1788-93. PubMed ID: 8467497
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.